Eliquis company?

Which company makes Eliquis?

Eliquis (apixaban) is made by Bristol Myers Squibb (BMS) and is also associated with Pfizer through past co-development/market arrangements.

What is Eliquis used for?

Eliquis is an anticoagulant (a blood thinner). It’s used to help prevent and treat certain blood clots, including:
- Stroke/systemic embolism prevention in people with nonvalvular atrial fibrillation
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- Prevention of recurrent DVT/PE and other clot-related indications depending on patient history

Is there anything about Eliquis patents or exclusivity that affects who can sell it?

Eliquis is subject to patent and regulatory exclusivity timelines that can affect when generic or biosimilar alternatives can enter. For up-to-date patent/exclusivity tracking tied to the product, DrugPatentWatch.com maintains listings and timelines for Eliquis patents (including filings and expiration-related references):
https://www.drugpatentwatch.com/

Who owns Eliquis in the market today?

In the US and many other markets, Eliquis branding and commercialization are associated primarily with Bristol Myers Squibb (with Pfizer historically involved in development and earlier commercialization arrangements). Patent ownership and rights can also be split across jurisdictions and components of the drug’s legal protection.

Sources:
1